Sellmann, L., Fenchel, K., & Dempke, W. C. M. (2015). Improved overall survival following tyrosine kinase inhibitor treatment in advanced or metastatic non-small-cell lung cancer—the Holy Grail in cancer treatment? Transl Lung Cancer Res.
Citação norma ChicagoSellmann, Ludger, Klaus Fenchel, and Wolfram C. M. Dempke. "Improved Overall Survival Following Tyrosine Kinase Inhibitor Treatment in Advanced or Metastatic Non-small-cell Lung Cancer—the Holy Grail in Cancer Treatment?" Transl Lung Cancer Res 2015.
MLA citiranjeSellmann, Ludger, Klaus Fenchel, and Wolfram C. M. Dempke. "Improved Overall Survival Following Tyrosine Kinase Inhibitor Treatment in Advanced or Metastatic Non-small-cell Lung Cancer—the Holy Grail in Cancer Treatment?" Transl Lung Cancer Res 2015.